VTVT

vTv Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing innovative orally administered small molecule therapies aimed at addressing significant unmet medical needs, particularly in central nervous system disorders and metabolic diseases. The company boasts a robust pipeline and a seasoned management team that is committed to advancing healthcare solutions through strategic collaborations. With its dedication to bringing transformative therapies to market, vTv Therapeutics is well-positioned to enhance patient outcomes and drive shareholder value in an evolving healthcare landscape.